Lenz, Q F <br/><br/>
Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.  [electronic resource] 

 -  Neuroscience  Sep 2014 
 - 859-71 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2014.07.058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--pharmacology<br/>Animals<br/>Anticonvulsants--pharmacology<br/>Blood-Brain Barrier--drug effects<br/>Brain--drug effects<br/>Capillary Permeability--drug effects<br/>Chromones--pharmacology<br/>Cyclopropanes<br/>Dose-Response Relationship, Drug<br/>Immunoglobulin G--metabolism<br/>Leukocyte Common Antigens--metabolism<br/>Leukocytes--drug effects<br/>Leukotriene Antagonists--pharmacology<br/>Leukotriene D4--pharmacology<br/>Male<br/>Mice<br/>Neuroprotective Agents--pharmacology<br/>Pentylenetetrazole<br/>Quinolines--pharmacology<br/>Receptors, Leukotriene--agonists<br/>SRS-A--analogs & derivatives<br/>Seizures--drug therapy<br/>Sulfides